Agreement to Defer Market Entry of Generic Drug in Exchange for Payment in Patent-Dispute Settlement Violates Antitrust Laws.
Mondaq Business Briefing › Nbr. 2004, May 2004
Linked as:
Summary
Schering-Plough Corp
See the full content of this document
Extract
Agreement to Defer Market Entry of Generic Drug in Exchange for Payment in Patent-Dispute Settlement Violates Antitrust Laws.
In a case that raised significant policy issues at the intersection of patent and antitrust law, the U.S. Federal Trade Commission (FTC) issued a final order and opinion that...
See the full content of this document
Sponsored links
